Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
recent
Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment
May
9
,
2024
Compass Pathways COMP360 Delivers on Phase 2 Results
May
9
,
2024
Psychedelics Without the Trip Show Antidepressant Potential
May
9
,
2024
BetterLife Pharma Set to Begin Human Trials for LSD Derivative
May
3
,
2024
FDA Approves IND Application for Freedom’s Ketamine-Based Combination Therapy
April
26
,
2024
Lykos Completes European Phase 2 Study for MDMA-Assisted Therapy
April
24
,
2024
«
‹
4
5
6
7
›
»